Published in J Immunol on December 15, 1988
Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci U S A (1993) 1.77
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med (1992) 1.53
Clonal CD8+ T Cell Persistence and Variable Gene Usage Bias in a Human Transplanted Hand. PLoS One (2015) 1.42
The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol (1981) 7.05
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation (1991) 4.37
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet (1998) 3.77
QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation (1991) 3.25
Y-antigen killing by T cells of women is restricted by HLA. Nature (1977) 2.73
Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol (1997) 2.70
Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation (1994) 2.68
Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation (2001) 2.65
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
DNA probe localization at 18p113 band by in situ hybridization and identification of a small supernumerary chromosome. Hum Genet (1985) 2.59
Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science (1995) 2.55
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity (1997) 2.45
Unusual fat-containing tumors of the kidney: a diagnostic dilemma. Radiographics (1997) 2.14
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med (1994) 2.14
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet (1997) 2.12
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science (1998) 2.11
Non-paternity and genetic counselling. Lancet (1992) 2.09
Characterization of a set of X-linked sequences and of a panel of somatic cell hybrids useful for the regional mapping of the human X chromosome. Hum Genet (1986) 1.92
Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest (1999) 1.91
Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant (2010) 1.88
Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science (1995) 1.87
Comparison of different rates of artificial ventilation in preterm neonates with respiratory distress syndrome. Acta Paediatr Scand (1987) 1.87
Diagnosis of brain death using two-phase spiral CT. AJNR Am J Neuroradiol (1998) 1.86
High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. Hum Mutat (2001) 1.80
The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity (1997) 1.78
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78
Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (1992) 1.76
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol (1999) 1.68
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1999) 1.62
Fighting the ventilator--are fast rates an effective alternative to paralysis? Early Hum Dev (1986) 1.61
Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus. Mutat Res (2001) 1.59
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J (1993) 1.54
Risk ratio and rate ratio estimation in case-cohort designs: hypertension and cardiovascular mortality. Stat Med (1993) 1.53
Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3. Genomics (1997) 1.52
Success and failure of exercise training after myocardial infarction: is the outcome predictable? J Am Coll Cardiol (1990) 1.47
Metabolic acidosis of exercise in healthy males. J Appl Physiol (1966) 1.45
[Imaging of thyroid nodules]. J Radiol (1999) 1.41
Expression pattern, genomic structure and evaluation of the human SLC30A4 gene as a candidate for acrodermatitis enteropathica. Hum Genet (2001) 1.40
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol (1999) 1.38
Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant (2013) 1.36
A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature (1983) 1.34
Genetic analysis of the fragile-X mental retardation syndrome with two flanking polymorphic DNA markers. Proc Natl Acad Sci U S A (1986) 1.34
Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction. Eur Heart J (1992) 1.33
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med (1976) 1.33
The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein. Mol Cell Biol (1992) 1.30
Renal cell carcinoma containing fat: demonstration with CT. Radiology (1993) 1.29
Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet (1995) 1.29
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell (1994) 1.29
Abnormalities of lung mechanics in young asthmatic children. Thorax (1987) 1.28
Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int (1973) 1.27
Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation (1993) 1.27
Neonatal patient triggered ventilation. Arch Dis Child (1988) 1.26
Cell-mediated lympholysis studies in renal allograft recipients. Transplantation (1981) 1.25
Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis (2001) 1.23
Spatial and temporal distribution of the neutral polymorphisms in the last ZFX intron: analysis of the haplotype structure and genealogy. Genetics (1999) 1.21
Alloimmunity to human H-Y. Lancet (1976) 1.20
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet (1990) 1.19
Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens (1998) 1.18
A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity. J Immunol (1987) 1.17
Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism. J Exp Med (1997) 1.17
Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum (1994) 1.15
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int (1998) 1.15
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol (2001) 1.14
Homologies between X and Y chromosomes detected by DNA probes: localisation and evolution. Nucleic Acids Res (1985) 1.13
Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients. Transplantation (1997) 1.13
A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest (1998) 1.13
Eggs, serum cholesterol, and coronary heart disease. Am J Clin Nutr (1982) 1.13
Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis (1999) 1.12
Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol (1995) 1.12
Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation (1994) 1.10
Haemangioblastoma, haemangioblastomatosis, and von Hippel-Lindau disease. Adv Tech Stand Neurosurg (1993) 1.10
Detection of mycobacteria using the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1992) 1.10
Anti-self HLA may be clonally expressed. J Exp Med (1979) 1.10
Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood (1996) 1.10
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes. J Immunol (1983) 1.09
Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood (1994) 1.08
The therapeutic actions of theophylline in preterm ventilated infants. Early Hum Dev (1985) 1.08
Imaging in male hypofertility and impotence. BJU Int (2000) 1.08
CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J Immunol (1997) 1.08
Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation. Early Hum Dev (1988) 1.07
Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet (1998) 1.07